Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Michael Wessolly"'
Autor:
Elena Mairinger, Michael Wessolly, Paul Buderath, Sabrina Borchert, Larissa Henrich, Pawel Mach, Julia Steinborn, Rainer Kimming, Bharat Jasani, Kurt Werner Schmid, Agnes Bankfalvi, Fabian Dominik Mairinger
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe underlying mechanism of high T-cell presence as a favorable prognostic factor in high-grade serous ovarian carcinoma (HGSOC) is not yet understood. In addition to immune cells, various cofactors are essential for immune processes. One o
Externí odkaz:
https://doaj.org/article/61da0f0817b3496bb034186b8ace0936
Autor:
Karim Al-Ghazzawi, Michael Wessolly, Sami Dalbah, Petra Ketteler, Tobias Kiefer, Nikolaos Bechrakis, Jabbarli Leyla, Saskia Ting, Eva Biewald, Fabian D. Mairinger
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Retinoblastoma (RB) is the most common form of eye cancer experienced in childhood. Its aggressive malignancy is associated with excellent survival rates in high-income countries; however, the prognosis in third-world countries is less favorable. Ear
Externí odkaz:
https://doaj.org/article/639511dd49ed43fe84c5fd225e98e4d4
Autor:
Michael Wessolly, Susann Stephan-Falkenau, Anna Streubel, Marcel Wiesweg, Sabrina Borchert, Elena Mairinger, Jens Kollmeier, Henning Reis, Torsten Bauer, Kurt Werner Schmid, Thomas Mairinger, Martin Schuler, Fabian D. Mairinger
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Immune checkpoint inhibitors (ICIs) are currently one of the most promising therapy options in the field of oncology. Although the first pivotal ICI trial results were published in 2011, few biomarkers exist to predict their thera
Externí odkaz:
https://doaj.org/article/ba9aee6c71794d6f8106a205ed38e4c9
Autor:
Michael Wessolly, Elena Mairinger, Sabrina Borchert, Agnes Bankfalvi, Pawel Mach, Kurt Werner Schmid, Rainer Kimmig, Paul Buderath, Fabian Dominik Mairinger
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundHigh-grade serous ovarian cancer (HGSOC) is the predominant and deadliest form of ovarian cancer. Some of its histological subtypes can be distinguished by frequent occurrence of cancer-associated myofibroblasts (CAFs) and desmoplastic stro
Externí odkaz:
https://doaj.org/article/2d03341162de4358a573bb7f97a982f0
Autor:
Sabrina Borchert, Michael Wessolly, Jan Schmeller, Elena Mairinger, Jens Kollmeier, Thomas Hager, Thomas Mairinger, Thomas Herold, Daniel C. Christoph, Robert F. H. Walter, Wilfried E. E. Eberhardt, Till Plönes, Jeremias Wohlschlaeger, Clemens Aigner, Kurt Werner Schmid, Fabian D. Mairinger
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Malignant pleural mesothelioma (MPM) is a tumour arising from pleural cavities with poor prognosis. Multimodality treatment with pemetrexed combined with cisplatin shows unsatisfying response-rates of 40%. The reasons for the rath
Externí odkaz:
https://doaj.org/article/a78dfbb5af2449eea6d8fb6a3f276409
Autor:
Susann Stephan-Falkenau, Anna Streubel, Thomas Mairinger, Jens Kollmeier, Daniel Misch, Sebastian Thiel, Torsten Bauer, Joachim Pfannschmidt, Manuel Hollmann, Michael Wessolly, Torsten Gerriet Blum
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 20; Pages: 12511
Precision oncology and immunotherapy have revolutionized the treatment of advanced non-small-cell lung cancer (NSCLC). Emerging studies show that targeted therapies are also beneficial for patients with driver alterations such as epidermal growth fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::452782a6b3da5fc2fecbfd12e3b998df
Autor:
Reis, Michael Wessolly, Fabian D. Mairinger, Thomas Herold, Boris Hadaschik, Tibor Szarvas, Henning
Publikováno v:
Genes; Volume 13; Issue 3; Pages: 422
In recent years, the number and type of treatment options in advanced bladder cancer (BC) have been rapidly evolving. To select an effective therapy and spare unnecessary side effects, predictive biomarkers are urgently needed. As the host’s anti-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::e9d772b5549aad7617ed0de303603eb9
Autor:
Alexander Mathilakathu, Michael Wessolly, Elena Mairinger, Hendrik Uebner, Daniel Kreidt, Luka Brcic, Julia Steinborn, Kristina Greimelmaier, Jeremias Wohlschlaeger, Kurt Werner Schmid, Fabian D. Mairinger, Sabrina Borchert
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 6; Pages: 3278
Background: Malignant pleural mesothelioma (MPM) has an infaust prognosis due to resistance to systemic treatment with platin-analoga. MPM cells modulate the immune response to their benefit. They release proinflammatory cytokines, such as TGF-ß, aw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f626a8f7d9941e813a7c96350b2c671
https://pubmed.ncbi.nlm.nih.gov/35328699
https://pubmed.ncbi.nlm.nih.gov/35328699
Autor:
Thomas Herold, Wildfried E. E. Eberhardt, Pia-Maria Suckrau, Jeremias Wohlschlaeger, Clemens Aigner, Kurt Werner Schmid, Agnes Bankfalvi, Michael Wessolly, Fabian Dominik Mairinger, Robert Fred Henry Walter, Elena Mairinger, Balazs Hegedus, Thomas Hager, Sabrina Borchert
Publikováno v:
Journal of Oncology, Vol 2019 (2019)
Journal of Oncology
Journal of Oncology
Background. Malignant pleural mesothelioma (MPM) is a rare, predominantly asbestos-related and biologically highly aggressive tumor associated with a dismal prognosis. Multimodal therapy consisting of platinum-based chemotherapy is the treatment of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0c8a4ac774f736984f0d5f26ef6fda
https://doi.org/10.1155/2019/2902985
https://doi.org/10.1155/2019/2902985
Autor:
Michael, Wessolly, Fabian D, Mairinger, Thomas, Herold, Boris, Hadaschik, Tibor, Szarvas, Henning, Reis
Publikováno v:
Genes. 13(3)
In recent years, the number and type of treatment options in advanced bladder cancer (BC) have been rapidly evolving. To select an effective therapy and spare unnecessary side effects, predictive biomarkers are urgently needed. As the host's anti-can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17743516354f4167a3cf26f612b914c1
https://pubmed.ncbi.nlm.nih.gov/35327977
https://pubmed.ncbi.nlm.nih.gov/35327977